Influence of wound fluid on chemotherapy sensitivity in primary breast cancer cells
Metrics: PDF 842 views | HTML 810 views | ?
Yingchao Zhang1,*, Dong Yan2,*, Hao Zhang3, Xunyan Ou3, Zuowei Zhao3, Dan Wang3, Caigang Liu3
1Department of Breast Surgery, The Second Hospital of JiLin University, Changchun, 130021, China
2Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, 114006, China
3Breast Disease and Reconstruction Center, Breast Cancer Key Laboratory of Dalian, The Second Hospital of Dalian Medical University, Dalian, 114006, China
Caigang Liu, email: firstname.lastname@example.org
Keywords: breast cancer, wound fluid, chemotherapy, drug resistance
Received: April 10, 2016 Accepted: August 10, 2016 Published: August 17, 2016
Objective: To investigate the effect of WF on chemotherapy sensitivities of primary breast cancer cells from breast cancer patients by using CD-DST.
Results: In general, the WF-treated cells showed remarkable increase in survival rates as compared to the control cells cultured without WF among different anticancer drug subgroups. This trend was generally observed in all the tumor cells from the premenopausal, postmenopausal, T2, N0, N1, luminal B, and TN patients.
Methods: The sensitivities of WF-treated primary breast cancer cells, from 21 patients who underwent a radical resection for breast cancer from September 2014 to July 2015, to anticancer drugs: EPI, CDDP, DOC, VNR, 5-FU+LV, and PAC, were obtained using CD-DST. The survival rates of the breast cancer cells were recorded and used to gauge the chemotherapeutic effect.
Conclusions: Surgery-induced WF promotes the drug resistance of primary breast cancer cells to chemotherapy, suggesting that surgery may have adverse effects on breast cancer patients. More studies are needed to investigate the key factors in WF that enhance the susceptibility to chemotherapy drugs.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.